β-Cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells
- 15 March 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (7) , 677-680
- https://doi.org/10.1016/s0960-894x(00)00078-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cyclodextrin as Carrier of Peptide Hormones. Conformational and Biological Properties of β-Cyclodextrin/Gastrin ConstructsJournal of the American Chemical Society, 1998
- Substrate/propeptide‐derived endo‐epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitorsFEBS Letters, 1998
- The cysteine protease cathepsin B in cancerPerspectives in Drug Discovery and Design, 1996
- Cyclodextrins as templates for the presentation of protease inhibitorsFEBS Letters, 1996
- Tumor protease-activated, pore-forming toxins from a combinatorial libraryNature Biotechnology, 1996
- Cyclodextrin Derivatives in PharmaceuticsCritical Reviews in Therapeutic Drug Carrier Systems, 1995
- Recognition ability and cytotoxicity of some oligosaccharidylsubstituted β‐cyclodextrinsBiology of the Cell, 1994
- A new approach to enhance bioavailability of biologically active peptides: conjugation of a δ opioid agonist to β-cyclodextrinBioorganic & Medicinal Chemistry Letters, 1993
- Synthesis of a new molecular carrier: N-(Leu-enkephalin)yl 6-amido-6-deoxy-cyclomaltoheptaoseTetrahedron Letters, 1993
- PyBOP®: A new peptide coupling reagent devoid of toxic by-productTetrahedron Letters, 1990